These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18064647)

  • 1. Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing's sarcoma family of tumors: a study by the United Kingdom Cancer Cytogenetics and the Children's Cancer and Leukaemia Group.
    Roberts P; Burchill SA; Brownhill S; Cullinane CJ; Johnston C; Griffiths MJ; McMullan DJ; Bown NP; Morris SP; Lewis IJ
    Genes Chromosomes Cancer; 2008 Mar; 47(3):207-20. PubMed ID: 18064647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors.
    Hattinger CM; Rumpler S; Strehl S; Ambros IM; Zoubek A; Pötschger U; Gadner H; Ambros PF
    Genes Chromosomes Cancer; 1999 Mar; 24(3):243-54. PubMed ID: 10451705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic abnormalities and clinical outcome in Wilms tumor: a study by the U.K. cancer cytogenetics group and the U.K. Children's Cancer Study Group.
    Bown N; Cotterill SJ; Roberts P; Griffiths M; Larkins S; Hibbert S; Middleton H; Kelsey A; Tritton D; Mitchell C
    Med Pediatr Oncol; 2002 Jan; 38(1):11-21. PubMed ID: 11835232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of secondary structural chromosomal changes in pediatric ewing sarcoma is a probable prognostic factor for tumor response and clinical outcome.
    Zielenska M; Zhang ZM; Ng K; Marrano P; Bayani J; Ramirez OC; Sorensen P; Thorner P; Greenberg M; Squire JA
    Cancer; 2001 Jun; 91(11):2156-64. PubMed ID: 11391597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ewing's sarcoma. Pathology, tissue culture, and cytogenetics.
    Maletz N; McMorrow LE; Greco A; Wolman SR
    Cancer; 1986 Jul; 58(2):252-7. PubMed ID: 3719518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities.
    Burchill SA
    J Clin Pathol; 2003 Feb; 56(2):96-102. PubMed ID: 12560386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isochromosome 11q in a case of Ewing's sarcoma.
    Bennett DD; Garvin AJ; Killough BW; Stanley WS
    Cancer Genet Cytogenet; 1987 Mar; 25(1):97-101. PubMed ID: 3467837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting survival outcomes of patients with non-metastatic Ewing's sarcoma family tumors in the spine: a retrospective analysis of 63 patients in a single center.
    Wan W; Lou Y; Hu Z; Wang T; Li J; Tang Y; Wu Z; Xu L; Yang X; Song D; Xiao J
    J Neurooncol; 2017 Jan; 131(2):313-320. PubMed ID: 27752884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's sarcoma family of tumors.
    López-Guerrero JA; Machado I; Scotlandi K; Noguera R; Pellín A; Navarro S; Serra M; Calabuig-Fariñas S; Picci P; Llombart-Bosch A
    Int J Cancer; 2011 Mar; 128(5):1139-50. PubMed ID: 20473914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ewing's tumour: novel recurrent chromosomal abnormalities demonstrated by molecular cytogenetic analysis of seven cell lines and one primary culture.
    Shing DC; Morley-Jacob CA; Roberts I; Nacheva E; Coleman N
    Cytogenet Genome Res; 2002; 97(1-2):20-7. PubMed ID: 12438733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.
    Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphometric analysis of DNA ploidy and nuclear cell cycle regulators in Ewing's sarcoma/primitive neuroectodermal tumor.
    Machado I; Ruiz-Sauri A; López-Guerrero JA; Llombart-Bosch A
    Anal Quant Cytol Histol; 2011 Apr; 33(2):101-10. PubMed ID: 21980612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester].
    Zhang YP; Wu JP; Li XT; Lei CX; Xu JZ; Yin M
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):644-8. PubMed ID: 22176986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience.
    Orr WS; Denbo JW; Billups CA; Wu J; Navid F; Rao BN; Davidoff AM; Krasin MJ
    Ann Surg Oncol; 2012 Nov; 19(12):3816-22. PubMed ID: 22739653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
    Bown N; Lastowska M; Cotterill S; O'Neill S; Ellershaw C; Roberts P; Lewis I; Pearson AD;
    Med Pediatr Oncol; 2001 Jan; 36(1):14-9. PubMed ID: 11464868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic studies on fine-needle aspiration samples from osteosarcoma and Ewing's sarcoma.
    Akerman M; Dreinhöfer K; Rydholm A; Willén H; Mertens F; Mitelman F; Mandahl N
    Diagn Cytopathol; 1996 Jul; 15(1):17-22. PubMed ID: 8807247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 22 abnormalities in Ewing's sarcoma.
    Davison EV; Pearson AD; Emslie J; Reid MM; Malcolm A; Craft AW
    J Clin Pathol; 1989 Aug; 42(8):797-9. PubMed ID: 2768519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
    Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
    Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic aberrations in Ewing sarcoma: are secondary changes associated with clinical outcome?
    Kullendorff CM; Mertens F; Donnér M; Wiebe T; Akerman M; Mandahl N
    Med Pediatr Oncol; 1999 Feb; 32(2):79-83. PubMed ID: 9950192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular abnormalities in Ewing's sarcoma.
    Burchill SA
    Expert Rev Anticancer Ther; 2008 Oct; 8(10):1675-87. PubMed ID: 18925858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.